HHTM

NEW YORK, NY — Nagish, a startup utilizing AI to improve communication accessibility for deaf and hard-of-hearing individuals, announced $16 million in new funding. This includes $11 million from a Series A round led by Canaan Partners, with participation from existing investors K5 Global, Tokyo Black, Cardumen Capital, Vertex Ventures Israel, Contour Venture Partners, and Precursor Ventures, along with the

In this episode, we welcome Dr. Jonathan Kil, the CEO and CMO of Sound Pharmaceuticals to discuss the latest developments in hearing loss treatment. With a distinguished background in auditory neuroscience and otolaryngology, Dr. Kil co-founded Sound Pharmaceuticals over 22 years ago with a mission to develop drug-based therapies for sensorineural hearing loss and tinnitus. He has led the company’s

A team of scientists from the University of Sharjah has unveiled a groundbreaking biosensor capable of detecting gene mutations responsible for hearing loss. This innovative sensor, composed of nanoparticles and nanoarrays of silver, provides precise and rapid diagnosis not only for hearing loss genes but also for other conditions such as cancer, Alzheimer’s, and thalassemia. The research, published in the

Researchers from MIT, Massachusetts Eye and Ear, Harvard Medical School, and Columbia University have developed an innovative implantable microphone that could pave the way for fully internal cochlear implants. This advancement could significantly improve the quality of life for cochlear implant users by eliminating the need for external hardware. Cochlear implants have improved the hearing of over a million people

OrCam is leveraging its expertise in AI-based devices to address the cocktail party problem in hearing technology with the introduction of OrCam Hear. The device, which made a notable debut at the Consumer Electronics Show (CES), uses advanced AI to isolate and enhance specific voices in noisy environments. This innovation aims to significantly improve the speech-to-noise ratio, making it easier

In a groundbreaking study from Michigan Medicine’s Kresge Hearing Research Institute, researchers have successfully created supranormal hearing in mice, shedding light on the causes of hidden hearing loss in humans. This remarkable achievement not only paves the way for potential human treatments but also provides crucial insights into auditory processing and hearing disorders. Advancing Auditory Science The research team, led

Click here to read the July 2024 NeuroAudiology Newsletter.

by Michael Piskosz & Bill Schiffmiller An audiologist and a hearing aid user walk into a bar. They sit down, order a drink, and begin to chat about all things noise, sound, and hearing. The conversation quickly shifts to auditory healthcare, a topic both are intimately familiar with but from vastly different perspectives. Michael, the audiologist and a seasoned professional,

An interdisciplinary study led by researchers from the University of South Florida (USF) and Indiana University has unveiled critical insights into the long-term effects of cisplatin-based chemotherapy on cancer survivors. Published in JAMA Oncology, the comprehensive research highlights the significant auditory challenges faced by survivors who have been treated with cisplatin. Long-Term Impact on Hearing The study tracked 100 testicular

CLAYTON, NORTH CAROLINA — Dr. Melissa Palmer, a practicing audiologist for nearly 30 years and owner of Clayton Audiology in Clayton, North Carolina, has long been dedicated to improving the lives of her patients through better hearing health. Her passion for community service and long-standing relationship with Widex motivated her participation in the Widex Community Giveback Day program, which donates